Literature DB >> 19656035

Lysophosphatidic Acid signals through specific lysophosphatidic Acid receptor subtypes to control key regenerative responses of human gingival and periodontal ligament fibroblasts.

Joju George1, Karmel V Headen, Afolabi O Ogunleye, Greg A Perry, Terrence M Wilwerding, Lawrence C Parrish, Timothy P McVaney, John S Mattson, D Roselyn Cerutis.   

Abstract

BACKGROUND: We showed that the pluripotent platelet growth factor and mediator lysophosphatidic acid (LPA) controls key regenerative responses of human gingival fibroblasts (GFs) and periodontal ligament fibroblasts (PDLFs) and positively modulates their responses to platelet-derived growth factor (PDGF). This study determined which LPA receptor (LPAR) subtype(s) LPA signals through to stimulate mitogenic extracellular signal-regulated kinase (ERK) 1/2 signaling and chemotaxis and to elicit intracellular Ca(2+) increases in GFs and PDLFs because many healing responses are calcium-dependent.
METHODS: Activation of mitogen-activated protein kinase was determined using Western blotting with an antibody to phosphorylated ERK1/2. Migration responses were measured using a microchemotaxis chamber. GF and PDLF intracellular Ca(2+) mobilization responses to multiple LPA species and LPAR subtype-specific agonists were measured by using a cell-permeable fluorescent Ca(2+) indicator dye.
RESULTS: LPA stimulated ERK1/2 phosphorylation via LPA(1)(-3). For GFs, LPA(1) preferentially elicited chemotaxis, and LPA(1-3) for PDLFs, as confirmed using subtype-specific agonists. Elevation of intracellular calcium seems to be mediated through LPA(1) and LPA(3), with little, if any, contribution from LPA(2).
CONCLUSIONS: To the best of our knowledge, this study provides the first evidence that LPA signals through specific LPAR subtypes to stimulate human oral fibroblast regenerative responses. These data, in conjunction with our previous findings showing that LPA modulates GF and PDLF responses to PDGF, suggest that LPA is a factor of emerging importance to oral wound healing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656035     DOI: 10.1902/jop.2009.080624

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.

Authors:  S P Bathena; J Huang; M E Nunn; T Miyamoto; L C Parrish; M S Lang; T P McVaney; M L Toews; D R Cerutis; Y Alnouti
Journal:  J Pharm Biomed Anal       Date:  2011-06-06       Impact factor: 3.935

2.  Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts.

Authors:  D Roselyn Cerutis; Michael D Weston; Afolabi O Ogunleye; Timothy P McVaney; Takanari Miyamoto
Journal:  Genom Data       Date:  2014-10-23

3.  Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells.

Authors:  Ingvild J Brusevold; Ingun H Tveteraas; Monica Aasrum; John Ødegård; Dagny L Sandnes; Thoralf Christoffersen
Journal:  BMC Cancer       Date:  2014-06-13       Impact factor: 4.430

4.  Transcriptional Analysis Reveals Key Genes in the Pathogenesis of Nifedipine-Induced Gingival Overgrowth.

Authors:  Yanqin Ju; Lijuan Huang; Shuwei Wang; Shouliang Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2020-05-13       Impact factor: 2.916

Review 5.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.